$VXRT some points from the conference: CSO: Maybe human challenge study with omicron in order to speed up development (omicron is less severe) CSO: With S only more IgA antibodies in the nose as with "S+N" CMO was the missing link. He contributed to credibility.
2
14
14 Likes